Straight to content

Organisations call for greater social impact of the European Commission’s medical research and innovation investments

Posted in category:
Statement
Published on:

Together with 22 civil society organisations, SOMO calls on the European Commission to seize the opportunity during the preparation of   , to increase the social impact of its medical Research & Innovation investments and to generate more significant public return. The EC can do this by funding medical research and innovation projects that focus on unmet health needs and attaching access conditions to this funding so ensure public return on public investment.

Do you need more information?

Partners

  • Access to Medicines Ireland

  • Altroconsumo, associazione indipendente di consumatori (Italy)

  • BEUC – the European Consumer Organisation

  • BUKO Pharma-Kampagne (Germany)

  • Commons Network

  • EKPIZO – Consumer Association the Quality of Life (Greece)

  • EPHA- European Public Health Alliance

  • France Assos Santu00e9 (France)

  • Global Health Advocates

  • HAI – Health Action International

  • Just Treatment (UK)

  • Mu00e9dicins sans Frontiu00e8res Access Campaign

  • OCU – Organizaciu00f3n de Consumidores y Usuarios (Spain) 16. PRAKSIS

  • PRAKSIS (Greece)

  • Prescrire

  • Salud por Derecho (Spain)

  • SPARC Europe

  • STOPAIDS UK

  • Test-Aankoop/Test-Achats (Belgium)

  • Universities Allied for Essential Medicines (UAEM) – Europe

Download

Posted in category:
Statement
Published on:

Related news

Don't want to miss anything?

Sign up for our newsletter and always stay up to date on information and analysis on corporate power issues.